Hu Qiu

Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)

Wensi Zhao, Jun Lei, Shaobo Ke et al. · EClinicalMedicine · 2023 · 95 citations · Full text

Dysbiosis, Phase Ii Trial, Medicine +8

MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1

Shaobo Ke, Hu Qiu, Jiamei Chen et al. · Gene · 2018 · 63 citations

Medicine, Colorectal Cancer, Cancer Cell Biology +11

ALG3 contributes to the malignancy of non-small cell lung cancer and is negatively regulated by MiR-98-5p

Shaobo Ke, Hu Qiu, Jiamei Chen et al. · Pathology - Research and Practice · 2019 · 49 citations · Full text

Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial

Wensi Zhao, Shaobo Ke, Xiaojun Cai et al. · Radiotherapy and Oncology · 2023 · 38 citations

Esophageal Cancer, Phase Ii Trial, Radiation Therapy +9

Knockdown of circRNA circ_0087378 Represses the Tumorigenesis and Progression of Esophageal Squamous Cell Carcinoma Through Modulating the miR-140-3p/E2F3 Axis

Jing Wang, Qiushuang Wang, Yi Gong et al. · Frontiers in Oncology · 2021 · 25 citations · Full text